tiprankstipranks
The Fly

Mirum Pharmaceuticals sees FY25 revenue $420M-$435M, consensus $418.15M

Mirum Pharmaceuticals sees FY25 revenue $420M-$435M, consensus $418.15M

The company said, “2025 Guidance: expect continued revenue growth with global net product sales of approximately $420 million to $435 million and positive cash flow from operations.”

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Questions or Comments about the article? Write to editor@tipranks.com